B2TI22 AF NFT

Type III pantothenate kinase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibguwb7bzsyees7cr4x7cnkxuaau3mfd2cwbj4gybtkm3o4zgrkoi/metadata.json
IPFS of structure file: 
bafybeie2mfzt2n2tot4zkej2lvzhcrecx4nwehh3orprtqmbpbizk75sgq/AF-B2TI22-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x0A70d3367d1cE30ff1149924db0112B10f5dbed3
First NFT owner address (bech32): 
genesis1pfcdxdnarn3slug5nyjdkqgjky84m0knyjm3ax
Current NFT ID #70459 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
70459
Accession (UniProt):
B2TI22
Name::
Type III pantothenate kinase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TI22 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TI22|COAX_CLOBB Type III pantothenate kinase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=coaX PE=3 SV=1 MILLVDAGNTNIVLGVYKDKKYIASWRISTEGNKTSDEYSIQIIQLLNLNNLNPEDVKGIIVSSVVPNIMHSLENMLRRCFGQEPIIVGPGIKTGINIKYDNPKEVGADRIVNAVAAFEIYKRPVIIIDFGTATTFCSVTENGDYLGGCICPGLRISADALFERAAKLPRVELEVPKKVICKNTVSSIQSGVLFGYIGQVEYIVKKMKEEMSDGIEPYVIATGGLANLIANETDAIDEVDSDLTLEGLKILYQKNRE